Search results

A desire to give people around the world greater access to the benefits of nuclear medicine is behind Robert Raposio and his research into producing radioisotopes in more efficient, cheaper and sustainable ways.

Australian and New Zealand Society of Nuclear Medicine recognises Nigel Lengkeek

The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

ANSTO and the Embassy of Argentina in Australia proudly hosted an event commemorating the 15th anniversary of the opening of the Open Pool Australian Lightwater (OPAL) multi-purpose nuclear reactor on 18 October.

ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.

ANSTO completed an international overnight dash for nuclear medicine earlier this week, chartering three planes to get potentially life-saving children’s cancer treatments from Japan to hospitals across Australia.

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

The final report on the safety of Building 23 by the independent expert review team has been completed.

ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.

Frequently asked questions about ANSTO for the community.

Publications highlights three young researchers

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

ANSTO has responsibilities mandated by the Australian Government for the maintenance of the national measurement standard for radioactivity.

Commitment to undertake health research.

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.